Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)

NCT04747912 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Enrollment goal met; pending amendment to expand study

Conditions

Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia
ph+ Acute Lymphoblastic Leukemia

Interventions

DRUG: Inotuzumab ozogamicin
DRUG: Dasatinib
DRUG: Dexamethasone
DRUG: Methotrexate
DRUG: Vincristine
DRUG: Ponatinib
DRUG: Methotrexate for Injection
PROCEDURE: Allogenic Stem Cell Transplantation

Sponsor

University of Chicago